Tempest Therapeutics Inc. buy Vassago1
Start price
19.06.24
/
50%
€3.44
Target price
19.06.25
-
Performance (%)
-48.08%
End price
21.06.24
€1.79
Summary
This prediction ended on 21.06.24 with a price of €1.79. Massive losses of -48.08% were the result for the BUY prediction by Vassago1. Vassago1 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Tempest Therapeutics Inc. | -2.151% | -2.151% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
According to Vassago1 what are the pros and cons of Tempest Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Vassago1 for this prediction
In the thread Tempest Therapeutics Inc. diskutieren
Buy Tempest Therapeutics Inc.
In the thread Trading Tempest Therapeutics Inc.
Buy beendet
Stopped prediction by Vassago1 for Tempest Therapeutics Inc.
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.72
15.08.24
15.08.24
-
15.08.25
15.08.25
-25.41%
17.08.24
17.08.24
Could be very worthwhile Investment >20% year
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.72
24.11.23
24.11.23
-
24.11.24
24.11.24
-21.51%
09.12.23
09.12.23
Could be very worthwhile Investment >20% year
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.05
11.10.23
11.10.23
-
11.10.24
11.10.24
423.81%
12.10.23
12.10.23
Could be very worthwhile Investment >20% year
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.00
28.04.23
28.04.23
-
28.04.24
28.04.24
-35.00%
28.04.23
28.04.23
Could be very worthwhile Investment >20% year
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.89
15.07.21
15.07.21
-
15.07.22
15.07.22
-16.68%
24.07.21
24.07.21
Could be very worthwhile Investment >20% year
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.05
08.04.21
08.04.21
-
08.04.22
08.04.22
-3.49%
09.04.21
09.04.21
Could be very worthwhile Investment >20% year